Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Rosales, Xiomara Q ^a,b   Moser, Sean J ^c   Tran, Tam ^c   McCarthy, Beth ^c   Dunn, Nicholas ^c   Habib, Philip ^c   Simonetti, Orlando P ^c   Mendell, Jerry R ^a,b   Raman, Subha V ^c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN; FUKUTIN RELATED PROTEIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DYSF PROTEIN, HUMAN; FKTN PROTEIN, HUMAN; MEMBRANE PROTEIN; MUSCLE PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLE; CARDIOMYOPATHY; FIBROSIS; GENETIC PREDISPOSITION; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; UNITED STATES;

ADULT; CARDIOMYOPATHIES; CHILD; CONTRAST MEDIA; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; MYOCARDIUM; OHIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84555223124     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-39     Document Type: Article

References (47)

1. Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Guglieri M, Magri F, D'Angelo MG, Prelle A, Morandi L, Rodolico C, Cagliani R, Mora M, Fortunato F, Bordoni A, et al. Hum Mutat 2008 29 258 266 10.1002/humu.20642 17994539 (Pubitemid 351240598)
2. Limb-girdle muscular dystrophies. Guglieri M, Straub V, Bushby K, Lochmuller H, Curr Opin Neurol 2008 21 576 584 10.1097/WCO.0b013e32830efdc2 18769252
3. A novel autosomal recessive limb-girdle muscular dystrophy with quadriceps atrophy maps to 11p13-p12. Jarry J, Rioux MF, Bolduc V, Robitaille Y, Khoury V, Thiffault I, Tetreault M, Loisel L, Bouchard JP, Brais B, Brain 2007 130 368 380 10.1093/brain/awl270 17008331 (Pubitemid 46181091)
4. Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation. Muller T, Krasnianski M, Witthaut R, Deschauer M, Zierz S, Neuromuscul Disord 2005 15 372 376 10.1016/j.nmd.2005.02.004 15833432
5. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A, Siciliano G, Angelini C, Pegoraro E, Arch Neurol 2005 62 1894 1899 10.1001/archneur.62.12.1894 16344347 (Pubitemid 41785083)
6. Degenerative muscular disorder. Goetz C, Textbook of Clinical Neurology 2007
7. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Kaspar RW, Allen HD, Ray WC, Alvarez CE, Kissel JT, Pestronk A, Weiss RB, Flanigan KM, Mendell JR, Montanaro F, Circ Cardiovasc Genet 2009 2 544 551 10.1161/CIRCGENETICS.109.867242 20031633
8. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR, Muscle Nerve 2009 39 283 296 10.1002/mus.21244 19208403
9. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy. Illarioshkin SN, Ivanova-Smolenskaya IA, Greenberg CR, Nylen E, Sukhorukov VS, Poleshchuk VV, Markova ED, Wrogemann K, Neurology 2000 55 1931 1933 11134403 (Pubitemid 32103985)
10. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Weiler T, Bashir R, Anderson LV, Davison K, Moss JA, Britton S, Nylen E, Keers S, Vafiadaki E, Greenberg CR, et al. Hum Mol Genet 1999 8 871 877 10.1093/hmg/8.5.871 10196377 (Pubitemid 29189055)
11. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, et al. Nat Genet 1998 20 31 36 10.1038/1682 9731526 (Pubitemid 28410339)
12. Dysferlinopathy associated with rigid spine syndrome. Nagashima T, Chuma T, Mano Y, Goto Y, Hayashi YK, Minami N, Nishino I, Nonaka I, Takahashi T, Sawa H, et al. Neuropathology 2004 24 341 346 10.1111/j.1440-1789.2004.00573.x 15641596 (Pubitemid 39664759)
13. Clinical heterogeneity in dysferlinopathy. Ueyama H, Kumamoto T, Horinouchi H, Fujimoto S, Aono H, Tsuda T, Intern Med 2002 41 532 536 10.2169/internalmedicine.41.532 12132520 (Pubitemid 34846253)
14. Limb-girdle muscular dystrophy in the United States. Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, Brown CA, Michele DE, Piccolo F, Winder TL, et al. J Neuropathol Exp Neurol 2006 65 995 1003 10.1097/01.jnen. 0000235854.77716.6c 17021404 (Pubitemid 44521800)
15. Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. Sveen ML, Thune JJ, Kober L, Vissing J, Arch Neurol 2008 65 1196 1201 10.1001/archneur.65.9.1196 18779423
16. Dysfunction of dysferlin-deficient hearts. Wenzel K, Geier C, Qadri F, Hubner N, Schulz H, Erdmann B, Gross V, Bauer D, Dechend R, Dietz R, et al. J Mol Med 2007 85 1203 1214 10.1007/s00109-007-0253-7 17828519 (Pubitemid 47622228)
17. LGMD2I in a North American population. Kang PB, Feener CA, Estrella E, Thorne M, White AJ, Darras BT, Amato AA, Kunkel LM, BMC Musculoskelet Disord 2007 8 115 10.1186/1471-2474-8-115 18036232 (Pubitemid 351178228)
18. Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Wahbi K, Meune C, Hamouda el H, Stojkovic T, Laforet P, Becane HM, Eymard B, Duboc D, Neuromuscul Disord 2008 18 650 655 10.1016/j.nmd.2008.06.365 18639457
19. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C, Muntoni F, Voit T, Straub V, Hilton-Jones D, et al. Ann Neurol 2004 56 738 741 10.1002/ana.20283 15505776 (Pubitemid 39540759)
20. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW, Gottliebson WM, J Am Coll Cardiol 2009 53 1204 1210 10.1016/j.jacc.2008.12.032 19341862
21. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E, Gottliebson WM, Int J Cardiovasc Imaging 2009 25 57 63 10.1007/s10554-008-9352-y 18686011
22. Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: A cardiovascular magnetic resonance study. Walcher T, Steinbach P, Spiess J, Kunze M, Gradinger R, Walcher D, Bernhardt P, Eur J Radiol 2010
23. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. D'Souza G, Sugar E, Ruby W, Gravitt P, Gillison M, J Clin Microbiol 2005 43 5526 5535 10.1128/JCM.43.11.5526-5535. 2005 16272481 (Pubitemid 41612325)
24. Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease. Raman SV, Simonetti OP, Cataland SR, Kraut EH, Haematologica 2006 91 1329 1335 17018381 (Pubitemid 44569805)
25. Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. Paelinck BP, de Roos A, Bax JJ, Bosmans JM, van Der Geest RJ, Dhondt D, Parizel PM, Vrints CJ, Lamb HJ, J Am Coll Cardiol 2005 45 1109 1116 10.1016/j.jacc.2004.12.051 15808772 (Pubitemid 40432447)
26. Myocardial ischemia in asymptomatic adults with repaired aortic coarctation. Cook SC, Ferketich AK, Raman SV, Int J Cardiol 2009 133 95 101 10.1016/j.ijcard.2007.12.015 18262666
27. A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. Pirat B, Khoury DS, Hartley CJ, Tiller L, Rao L, Schulz DG, Nagueh SF, Zoghbi WA, J Am Coll Cardiol 2008 51 651 659 10.1016/j.jacc.2007. 10.029 18261685 (Pubitemid 351186868)
28. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, Wansapura J, Klimeczek P, Al-Khalidi HR, Chung ES, et al. JACC Cardiovasc Imaging 2010 3 144 151 10.1016/j.jcmg.2009.11.006 20159640
29. New Doppler echocardiographic applications for the study of diastolic function. Garcia MJ, Thomas JD, Klein AL, J Am Coll Cardiol 1998 32 865 875 10.1016/S0735-1097(98)00345-3 9768704 (Pubitemid 28459571)
30. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. Nishimura RA, Tajik AJ, J Am Coll Cardiol 1997 30 8 18 10.1016/S0735-1097(97)00144-7 9207615 (Pubitemid 27357121)
31. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, et al. J Am Soc Echocardiogr 1996 9 736 760 10.1016/S0894-7317(96)90076-0 8887883
32. Brain MRI abnormalities in muscular dystrophy due to FKRP mutations. Quijano-Roy S, Marti-Carrera I, Makri S, Mayer M, Maugenre S, Richard P, Berard C, Viollet L, Leheup B, Guicheney P, et al. Brain Dev 2006 28 232 242 10.1016/j.braindev.2005.08.003 16368217
33. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, et al. Am J Hum Genet 2001 69 1198 1209 10.1086/324412 11592034 (Pubitemid 33124201)
34. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Sveen ML, Schwartz M, Vissing J, Ann Neurol 2006 59 808 815 10.1002/ana.20824 16634037 (Pubitemid 43673158)
35. Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Brown SC, Torelli S, Brockington M, Yuva Y, Jimenez C, Feng L, Anderson L, Ugo I, Kroger S, Bushby K, et al. Am J Pathol 2004 164 727 737 10.1016/S0002-9440(10)63160-4 14742276 (Pubitemid 38364686)
36. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Aoki M, Liu J, Richard I, Bashir R, Britton S, Keers SM, Oeltjen J, Brown HE, Marchand S, Bourg N, et al. Neurology 2001 57 271 278 11468312 (Pubitemid 32667361)
37. Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E. Fanin M, Nascimbeni AC, Angelini C, Neuromuscul Disord 2006 16 792 799 10.1016/j.nmd.2006.06.010 16934466 (Pubitemid 44646857)
38. What mechanisms underlie diastolic dysfunction in heart failure? Kass DA, Bronzwaer JG, Paulus WJ, Circ Res 2004 94 1533 1542 10.1161/01.RES.0000129254. 25507.d6 15217918 (Pubitemid 38856960)
39. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Moreo A, Ambrosio G, De Chiara B, Pu M, Tran T, Mauri F, Raman SV, Circ Cardiovasc Imaging 2009 2 437 443 19920041
40. Cardiac involvement in limb-girdle muscular dystrophy 2I: conventional cardiac diagnostic and cardiovascular magnetic resonance. Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, Zierz S, Grothues F, J Neurol 2006 253 1317 1322 10.1007/s00415-006-0213-0 16786213 (Pubitemid 44691556)
41. The CMR examination in heart failure. Raman SV, Simonetti OP, Heart Fail Clin 2009 5 283 300 v 10.1016/j.hfc.2009.02.002 19564009
42. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. Smith GC, Kinali M, Prasad SK, Bonne G, Muntoni F, Pennell DJ, Nihoyannopoulos P, J Cardiovasc Magn Reson 2006 8 723 730 10.1080/10976640600723862 16891232 (Pubitemid 44195994)
43. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Verhaert D, Richards K, Rafael-Fortney JA, Raman SV, Circ Cardiovasc Imaging 2011 4 67 76 10.1161/CIRCIMAGING.110.960740 21245364
44. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Ashford MW, Liu W, Lin SJ, Abraszewski P, Caruthers SD, Connolly AM, Yu X, Wickline SA, Circulation 2005 112 2462 2467 10.1161/CIRCULATIONAHA.104.516716 16216964 (Pubitemid 41504496)
45. Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging. Li W, Liu W, Zhong J, Yu X, J Cardiovasc Magn Reson 2009 11 40 10.1186/1532-429X-11-40 19849858
46. Dysferlin, dystrophy, and dilatative cardiomyopathy. Luft FC, J Mol Med 2007 85 1157 1159 10.1007/s00109-007-0252-8 17876566 (Pubitemid 47622227)
47. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, Campbell KP, J Clin Invest 2007 117 1805 1813 10.1172/JCI30848 17607357 (Pubitemid 47036314)